Ergebnis ihrer Suche nach Mitteilungen

DGAP-Ad-hoc 28.10.21 06:29 DGAP-Ad-hoc: Airbus SE
Airbus SE: Airbus reports Nine-Month (9m) 2021 results
DGAP-Ad-hoc 29.07.21 06:29 DGAP-Ad-hoc: Airbus SE
Airbus SE: Airbus reports Half-Year (H1) 2021 results
DGAP-Ad-hoc 27.05.21 07:55 DGAP-Ad-hoc: Airbus SE
Airbus SE: Airbus provides suppliers with an update on product[...]
DGAP-Ad-hoc 29.04.21 06:29 DGAP-Ad-hoc: Airbus SE
Airbus SE: Airbus reports First Quarter (Q1) 2021 results
DGAP-Ad-hoc 18.02.21 06:29 DGAP-Ad-hoc: Airbus SE
Airbus SE: Airbus reports Full-Year (FY) 2020 results
DGAP-Ad-hoc 21.01.21 17:35 DGAP-Ad-hoc: Airbus SE
Airbus updates production rates in response to market environment
DGAP-Ad-hoc 29.10.20 06:30 DGAP-Ad-hoc: Airbus SE
Airbus SE: Airbus reports Nine-Month (9m) 2020 results
DGAP-Ad-hoc 30.07.20 06:29 DGAP-Ad-hoc: Airbus SE
Airbus SE: Airbus reports Half-Year (H1) 2020 results
DGAP-Ad-hoc 30.06.20 19:26 DGAP-Ad-hoc: Airbus SE
Airbus plans to further adapt to COVID-19 environment
DGAP-Ad-hoc 29.04.20 06:29 DGAP-Ad-hoc: Airbus SE
Airbus SE: Airbus reports First Quarter (Q1) 2020 results
DGAP-Ad-hoc 08.04.20 18:20 DGAP-Ad-hoc: Airbus SE
Airbus provides update on March commercial aircraft orders & d[...]
DGAP-Ad-hoc 23.03.20 06:30 DGAP-Ad-hoc: Airbus SE
Airbus SE: Airbus announces measures to bolster liquidity and [...]
DGAP-Ad-hoc 17.03.20 07:52 DGAP-Ad-hoc: Airbus SE
Airbus SE: Airbus provides update on COVID-19 related measures
DGAP-Ad-hoc 02.03.20 17:45 DGAP-Ad-hoc: Airbus SE
Airbus SE: Airbus discloses share buyback transactions 24-27 F[...]
DGAP-Ad-hoc 13.02.20 06:29 DGAP-Ad-hoc: Airbus SE
Airbus SE: Airbus reports Full-Year (FY) 2019 results, deliver[...]
DGAP-Ad-hoc 13.02.20 05:56 DGAP-Ad-hoc: Airbus SE
Airbus SE: Airbus and the Government of Québec become sole own[...]
DGAP-Ad-hoc 31.01.20 18:30 DGAP-Ad-hoc: Airbus SE
Airbus reaches agreements with French, U.K. and U.S. authorities
DGAP-Ad-hoc 28.01.20 19:15 DGAP-Ad-hoc: Airbus SE
Airbus reaches agreement in principle with French, U.K. and U.[...]
DGAP-Ad-hoc 28.01.20 07:17 DGAP-Ad-hoc: Airbus SE
Airbus SE: Airbus' statement regarding media reports on French[...]
DGAP-Ad-hoc 18.12.19 17:45 DGAP-Ad-hoc: Airbus SE
Airbus discloses share buyback transactions 11-12 December 2019

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Symrise verlängert Vorstandsvertrag von Dr. Heinz-Jürgen Bertram vorzeitig bis 2025

01. Dezember 2021, 15:38

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

Original-Research: GBC Insider Focus Index (von GBC AG): GBC Insider Focus Index

01. Dezember 2021